TITLE

Review: Meglitinide analogues reduce glucose levels in type 2 diabetes, but morbidity and mortality effects are unknown

PUB. DATE
November 2007
SOURCE
ACP Journal Club;Nov/Dec2007, Vol. 147 Issue 3, p65
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article offers information on a study investigating the effectiveness of meglitinide analogues (MAs) for patients with type 2 diabetes mellitus (DM). It describes the procedure and randomized controlled trials (RCTs), that were conducted during the study. The study revealed that MAs reduce the glucose level in patients with type 2 DM, but its effects on the morbidity and mortality on the patients is unknown.
ACCESSION #
28019869

 

Related Articles

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics